Ophthalmic Drops Market by Type (Over-the-counter Eye Drops, Prescription Eye Drops), Category (Anesthetic Drops, Antibiotic Drops, Dilation Drops), End User, Indications - Global Forecast 2024-2030

Ophthalmic Drops Market by Type (Over-the-counter Eye Drops, Prescription Eye Drops), Category (Anesthetic Drops, Antibiotic Drops, Dilation Drops), End User, Indications - Global Forecast 2024-2030


The Ophthalmic Drops Market size was estimated at USD 1.22 billion in 2023 and expected to reach USD 1.31 billion in 2024, at a CAGR 7.11% to reach USD 1.98 billion by 2030.

Global Ophthalmic Drops Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Ophthalmic Drops Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Ophthalmic Drops Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Ophthalmic Drops Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Akorn, Inc., Alcon Inc., Amneal Pharmaceuticals, Inc., Apotex Inc., Bausch & Lomb Incorporated, Catalent, Inc., CVS Health, Duopharma Biotech Berhad, Geri-Care Pharmaceuticals Corp., Honeywell International Inc., ImprimisRx, Johnson & Johnson Services, Inc., KC Pharmaceuticals, Inc., Mankind Pharma Ltd., Mylan N.V., Novartis AG, OCuSOFT, Inc., Orimed Pharma Inc., Pfizer, Inc., Preferred Pharmaceuticals Inc., Prestige Consumer Healthcare Inc., ROHTO Pharmaceutical Co., Ltd., Sager Pharma Kft., Santen Pharmaceutical Co., Ltd., Similasan Corporation, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Wockhardt.

Market Segmentation & Coverage

This research report categorizes the Ophthalmic Drops Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
Over-the-counter Eye Drops
Prescription Eye Drops
Category
Anesthetic Drops
Antibiotic Drops
Dilation Drops
Glaucoma Drops
Steroid Drops
End User
Eye Clinic
Hospitals
Medical Institutes
Research Organizations
Indications
Age-Related Macular Degeneration
Cataract
Glaucoma
Inflammatory Diseases
Refractive Disorders
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Ophthalmic Drops Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Ophthalmic Drops Market?
3. What are the technology trends and regulatory frameworks in the Ophthalmic Drops Market?
4. What is the market share of the leading vendors in the Ophthalmic Drops Market?
5. Which modes and strategic moves are suitable for entering the Ophthalmic Drops Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Ophthalmic Drops Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising Prevalence of Ophthalmic Disease and Eye Infection among the Population
5.1.1.2. Growing Old Age Population and Associated Eye-Surgeries Worldwide
5.1.1.3. Growth of Vision Problems in Kids and Younger Population due to More Screen Time
5.1.2. Restraints
5.1.2.1. Systemic Side Effects of Ophthalmic Drops
5.1.3. Opportunities
5.1.3.1. New Research & Development Approach to Ophthalmic Drops
5.1.3.2. Increase in Investment for Ophthalmology Medication
5.1.4. Challenges
5.1.4.1. Patient-Reported Problems Related to Eye Drop Instillation and Product Recall
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Ophthalmic Drops Market, by Type
6.1. Introduction
6.2. Over-the-counter Eye Drops
6.3. Prescription Eye Drops
7. Ophthalmic Drops Market, by Category
7.1. Introduction
7.2. Anesthetic Drops
7.3. Antibiotic Drops
7.4. Dilation Drops
7.5. Glaucoma Drops
7.6. Steroid Drops
8. Ophthalmic Drops Market, by End User
8.1. Introduction
8.2. Eye Clinic
8.3. Hospitals
8.4. Medical Institutes
8.5. Research Organizations
9. Ophthalmic Drops Market, by Indications
9.1. Introduction
9.2. Age-Related Macular Degeneration
9.3. Cataract
9.4. Glaucoma
9.5. Inflammatory Diseases
9.6. Refractive Disorders
10. Americas Ophthalmic Drops Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Ophthalmic Drops Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Ophthalmic Drops Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. AbbVie Inc.
14.1.2. Akorn, Inc.
14.1.3. Alcon Inc.
14.1.4. Amneal Pharmaceuticals, Inc.
14.1.5. Apotex Inc.
14.1.6. Bausch & Lomb Incorporated
14.1.7. Catalent, Inc.
14.1.8. CVS Health
14.1.9. Duopharma Biotech Berhad
14.1.10. Geri-Care Pharmaceuticals Corp.
14.1.11. Honeywell International Inc.
14.1.12. ImprimisRx
14.1.13. Johnson & Johnson Services, Inc.
14.1.14. KC Pharmaceuticals, Inc.
14.1.15. Mankind Pharma Ltd.
14.1.16. Mylan N.V.
14.1.17. Novartis AG
14.1.18. OCuSOFT, Inc.
14.1.19. Orimed Pharma Inc.
14.1.20. Pfizer, Inc.
14.1.21. Preferred Pharmaceuticals Inc.
14.1.22. Prestige Consumer Healthcare Inc.
14.1.23. ROHTO Pharmaceutical Co., Ltd.
14.1.24. Sager Pharma Kft.
14.1.25. Santen Pharmaceutical Co., Ltd.
14.1.26. Similasan Corporation
14.1.27. Sun Pharmaceutical Industries Ltd.
14.1.28. Teva Pharmaceutical Industries Ltd.
14.1.29. Wockhardt
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. OPHTHALMIC DROPS MARKET RESEARCH PROCESS
FIGURE 2. OPHTHALMIC DROPS MARKET SIZE, 2023 VS 2030
FIGURE 3. OPHTHALMIC DROPS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. OPHTHALMIC DROPS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. OPHTHALMIC DROPS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. OPHTHALMIC DROPS MARKET DYNAMICS
FIGURE 7. OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2023 VS 2030 (%)
FIGURE 10. OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 12. OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2023 VS 2030 (%)
FIGURE 14. OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES OPHTHALMIC DROPS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES OPHTHALMIC DROPS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. OPHTHALMIC DROPS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. OPHTHALMIC DROPS MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings